PDB Short entry for 1DMT HEADER HYDROLASE 15-DEC-99 1DMT TITLE STRUCTURE OF HUMAN NEUTRAL ENDOPEPTIDASE COMPLEXED WITH PHOSPHORAMIDON COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEUTRAL ENDOPEPTIDASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: EXTRACELLULAR DOMAIN; COMPND 5 SYNONYM: NEPRILYSIN, NEP, ENKEPHALINASE, COMMON ACUTE LYMPHOCYTIC COMPND 6 LEUKEMIA ANTIGEN; COMPND 7 EC: 3.4.24.11; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SACCHAROMYCES CEREVISIAE; SOURCE 6 EXPRESSION_SYSTEM_COMMON: BAKER'S YEAST; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4932; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PPICZ-ALPHA KEYWDS HYDROLASE, METALLOPROTEASE, SIGNAL-ANCHOR EXPDTA X-RAY DIFFRACTION AUTHOR C.OEFNER,A.D'ARCY,M.HENNIG,F.K.WINKLER,G.E.DALE REVDAT 7 13-MAR-24 1DMT 1 SOURCE HETSYN REVDAT 6 29-JUL-20 1DMT 1 COMPND REMARK HETNAM LINK REVDAT 6 2 1 SITE REVDAT 5 13-JUL-11 1DMT 1 VERSN REVDAT 4 30-JUN-09 1DMT 1 HETATM REVDAT 3 24-FEB-09 1DMT 1 VERSN REVDAT 2 01-APR-03 1DMT 1 JRNL REVDAT 1 20-DEC-00 1DMT 0 JRNL AUTH C.OEFNER,A.D'ARCY,M.HENNIG,F.K.WINKLER,G.E.DALE JRNL TITL STRUCTURE OF HUMAN NEUTRAL ENDOPEPTIDASE (NEPRILYSIN) JRNL TITL 2 COMPLEXED WITH PHOSPHORAMIDON. JRNL REF J.MOL.BIOL. V. 296 341 2000 JRNL REFN ISSN 0022-2836 JRNL PMID 10669592 JRNL DOI 10.1006/JMBI.1999.3492 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 44255 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : 5 % REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2210 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5595 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 86 REMARK 3 SOLVENT ATOMS : 465 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.480 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1DMT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-DEC-99. REMARK 100 THE DEPOSITION ID IS D_1000010217. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-JUN-99 REMARK 200 TEMPERATURE (KELVIN) : 120.0 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM1A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.86633 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: SHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.09 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, AMMONIUM SULFATE, BIS TRIS, REMARK 280 PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.22667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 37.61333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 37.61333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 75.22667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6250 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 55810 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -92.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 112.84000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 202 CA - CB - CG ANGL. DEV. = 14.0 DEGREES REMARK 500 PRO A 319 C - N - CA ANGL. DEV. = 15.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 81 95.46 -164.44 REMARK 500 ASN A 172 61.38 38.05 REMARK 500 LEU A 199 -54.57 67.72 REMARK 500 ASN A 210 84.14 -151.63 REMARK 500 SER A 211 -34.60 -39.56 REMARK 500 LYS A 318 -96.84 -36.83 REMARK 500 LEU A 382 -169.71 -103.82 REMARK 500 ASN A 542 174.68 179.77 REMARK 500 SER A 565 126.11 -170.09 REMARK 500 ASN A 592 -60.47 -103.63 REMARK 500 ASP A 678 57.61 -92.24 REMARK 500 VAL A 748 -67.97 -125.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 755 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 583 NE2 REMARK 620 2 HIS A 587 NE2 101.3 REMARK 620 3 GLU A 646 OE1 94.1 108.6 REMARK 620 4 RDF A 750 O1P 115.9 127.5 104.3 REMARK 620 N 1 2 3 REMARK 630 REMARK 630 MOLECULE TYPE: GLYCOPEPTIDE ENZYME INHIBITOR REMARK 630 MOLECULE NAME: N-ALPHA-L-RHAMNOPYRANOSYLOXY(HYDROXYPHOSPHINYL)-L- REMARK 630 LEUCYL-L-TRYPTOPHAN REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 RDF A 750 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: RHA LEU TRP REMARK 630 DETAILS: NULL DBREF 1DMT A 54 749 UNP P08473 NEP_HUMAN 55 750 SEQRES 1 A 696 GLY ILE CYS LYS SER SER ASP CYS ILE LYS SER ALA ALA SEQRES 2 A 696 ARG LEU ILE GLN ASN MET ASP ALA THR THR GLU PRO CYS SEQRES 3 A 696 THR ASP PHE PHE LYS TYR ALA CYS GLY GLY TRP LEU LYS SEQRES 4 A 696 ARG ASN VAL ILE PRO GLU THR SER SER ARG TYR GLY ASN SEQRES 5 A 696 PHE ASP ILE LEU ARG ASP GLU LEU GLU VAL VAL LEU LYS SEQRES 6 A 696 ASP VAL LEU GLN GLU PRO LYS THR GLU ASP ILE VAL ALA SEQRES 7 A 696 VAL GLN LYS ALA LYS ALA LEU TYR ARG SER CYS ILE ASN SEQRES 8 A 696 GLU SER ALA ILE ASP SER ARG GLY GLY GLU PRO LEU LEU SEQRES 9 A 696 LYS LEU LEU PRO ASP ILE TYR GLY TRP PRO VAL ALA THR SEQRES 10 A 696 GLU ASN TRP GLU GLN LYS TYR GLY ALA SER TRP THR ALA SEQRES 11 A 696 GLU LYS ALA ILE ALA GLN LEU ASN SER LYS TYR GLY LYS SEQRES 12 A 696 LYS VAL LEU ILE ASN LEU PHE VAL GLY THR ASP ASP LYS SEQRES 13 A 696 ASN SER VAL ASN HIS VAL ILE HIS ILE ASP GLN PRO ARG SEQRES 14 A 696 LEU GLY LEU PRO SER ARG ASP TYR TYR GLU CYS THR GLY SEQRES 15 A 696 ILE TYR LYS GLU ALA CYS THR ALA TYR VAL ASP PHE MET SEQRES 16 A 696 ILE SER VAL ALA ARG LEU ILE ARG GLN GLU GLU ARG LEU SEQRES 17 A 696 PRO ILE ASP GLU ASN GLN LEU ALA LEU GLU MET ASN LYS SEQRES 18 A 696 VAL MET GLU LEU GLU LYS GLU ILE ALA ASN ALA THR ALA SEQRES 19 A 696 LYS PRO GLU ASP ARG ASN ASP PRO MET LEU LEU TYR ASN SEQRES 20 A 696 LYS MET THR LEU ALA GLN ILE GLN ASN ASN PHE SER LEU SEQRES 21 A 696 GLU ILE ASN GLY LYS PRO PHE SER TRP LEU ASN PHE THR SEQRES 22 A 696 ASN GLU ILE MET SER THR VAL ASN ILE SER ILE THR ASN SEQRES 23 A 696 GLU GLU ASP VAL VAL VAL TYR ALA PRO GLU TYR LEU THR SEQRES 24 A 696 LYS LEU LYS PRO ILE LEU THR LYS TYR SER ALA ARG ASP SEQRES 25 A 696 LEU GLN ASN LEU MET SER TRP ARG PHE ILE MET ASP LEU SEQRES 26 A 696 VAL SER SER LEU SER ARG THR TYR LYS GLU SER ARG ASN SEQRES 27 A 696 ALA PHE ARG LYS ALA LEU TYR GLY THR THR SER GLU THR SEQRES 28 A 696 ALA THR TRP ARG ARG CYS ALA ASN TYR VAL ASN GLY ASN SEQRES 29 A 696 MET GLU ASN ALA VAL GLY ARG LEU TYR VAL GLU ALA ALA SEQRES 30 A 696 PHE ALA GLY GLU SER LYS HIS VAL VAL GLU ASP LEU ILE SEQRES 31 A 696 ALA GLN ILE ARG GLU VAL PHE ILE GLN THR LEU ASP ASP SEQRES 32 A 696 LEU THR TRP MET ASP ALA GLU THR LYS LYS ARG ALA GLU SEQRES 33 A 696 GLU LYS ALA LEU ALA ILE LYS GLU ARG ILE GLY TYR PRO SEQRES 34 A 696 ASP ASP ILE VAL SER ASN ASP ASN LYS LEU ASN ASN GLU SEQRES 35 A 696 TYR LEU GLU LEU ASN TYR LYS GLU ASP GLU TYR PHE GLU SEQRES 36 A 696 ASN ILE ILE GLN ASN LEU LYS PHE SER GLN SER LYS GLN SEQRES 37 A 696 LEU LYS LYS LEU ARG GLU LYS VAL ASP LYS ASP GLU TRP SEQRES 38 A 696 ILE SER GLY ALA ALA VAL VAL ASN ALA PHE TYR SER SER SEQRES 39 A 696 GLY ARG ASN GLN ILE VAL PHE PRO ALA GLY ILE LEU GLN SEQRES 40 A 696 PRO PRO PHE PHE SER ALA GLN GLN SER ASN SER LEU ASN SEQRES 41 A 696 TYR GLY GLY ILE GLY MET VAL ILE GLY HIS GLU ILE THR SEQRES 42 A 696 HIS GLY PHE ASP ASP ASN GLY ARG ASN PHE ASN LYS ASP SEQRES 43 A 696 GLY ASP LEU VAL ASP TRP TRP THR GLN GLN SER ALA SER SEQRES 44 A 696 ASN PHE LYS GLU GLN SER GLN CYS MET VAL TYR GLN TYR SEQRES 45 A 696 GLY ASN PHE SER TRP ASP LEU ALA GLY GLY GLN HIS LEU SEQRES 46 A 696 ASN GLY ILE ASN THR LEU GLY GLU ASN ILE ALA ASP ASN SEQRES 47 A 696 GLY GLY LEU GLY GLN ALA TYR ARG ALA TYR GLN ASN TYR SEQRES 48 A 696 ILE LYS LYS ASN GLY GLU GLU LYS LEU LEU PRO GLY LEU SEQRES 49 A 696 ASP LEU ASN HIS LYS GLN LEU PHE PHE LEU ASN PHE ALA SEQRES 50 A 696 GLN VAL TRP CYS GLY THR TYR ARG PRO GLU TYR ALA VAL SEQRES 51 A 696 ASN SER ILE LYS THR ASP VAL HIS SER PRO GLY ASN PHE SEQRES 52 A 696 ARG ILE ILE GLY THR LEU GLN ASN SER ALA GLU PHE SER SEQRES 53 A 696 GLU ALA PHE HIS CYS ARG LYS ASN SER TYR MET ASN PRO SEQRES 54 A 696 GLU LYS LYS CYS ARG VAL TRP MODRES 1DMT ASN A 144 ASN GLYCOSYLATION SITE MODRES 1DMT ASN A 324 ASN GLYCOSYLATION SITE MODRES 1DMT ASN A 627 ASN GLYCOSYLATION SITE HET NAG A 752 14 HET NAG A 753 14 HET NAG A 754 14 HET ZN A 755 1 HET RDF A 750 37 HET GOL A 751 6 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM ZN ZINC ION HETNAM RDF N-ALPHA-L-RHAMNOPYRANOSYLOXY(HYDROXYPHOSPHINYL)-L- HETNAM 2 RDF LEUCYL-L-TRYPTOPHAN HETNAM GOL GLYCEROL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN RDF PHOSPHORAMIDON HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 NAG 3(C8 H15 N O6) FORMUL 5 ZN ZN 2+ FORMUL 6 RDF C23 H34 N3 O10 P FORMUL 7 GOL C3 H8 O3 FORMUL 8 HOH *465(H2 O) HELIX 1 1 SER A 58 MET A 72 1 15 HELIX 2 2 ASP A 81 GLY A 88 1 8 HELIX 3 3 CYS A 87 ASN A 94 1 8 HELIX 4 4 ASN A 105 GLN A 122 1 18 HELIX 5 5 ILE A 129 ASN A 144 1 16 HELIX 6 6 ASN A 144 ARG A 151 1 8 HELIX 7 7 GLY A 153 LEU A 160 1 8 HELIX 8 8 PRO A 161 TYR A 164 5 4 HELIX 9 9 TRP A 166 THR A 170 5 5 HELIX 10 10 ASN A 172 TYR A 177 1 6 HELIX 11 11 THR A 182 GLY A 195 1 14 HELIX 12 12 SER A 227 CYS A 233 5 7 HELIX 13 13 THR A 234 ILE A 236 5 3 HELIX 14 14 TYR A 237 GLU A 259 1 23 HELIX 15 15 ASP A 264 THR A 286 1 23 HELIX 16 16 LYS A 288 ARG A 292 5 5 HELIX 17 17 ASP A 294 TYR A 299 1 6 HELIX 18 18 LEU A 304 PHE A 311 1 8 HELIX 19 19 SER A 321 SER A 331 1 11 HELIX 20 20 THR A 332 ASN A 334 5 3 HELIX 21 21 ALA A 347 THR A 359 1 13 HELIX 22 22 SER A 362 VAL A 379 1 18 HELIX 23 23 SER A 380 LEU A 382 5 3 HELIX 24 24 SER A 383 SER A 389 1 7 HELIX 25 25 ARG A 390 GLY A 399 1 10 HELIX 26 26 ALA A 405 MET A 418 1 14 HELIX 27 27 MET A 418 PHE A 431 1 14 HELIX 28 28 GLU A 434 LEU A 457 1 24 HELIX 29 29 ASP A 461 ILE A 475 1 15 HELIX 30 30 ASP A 483 ASN A 488 1 6 HELIX 31 31 ASN A 488 TYR A 496 1 9 HELIX 32 32 GLU A 505 LYS A 523 1 19 HELIX 33 33 GLY A 557 LEU A 559 5 3 HELIX 34 34 SER A 569 GLY A 576 1 8 HELIX 35 35 GLY A 576 HIS A 587 1 12 HELIX 36 36 GLY A 588 ASP A 590 5 3 HELIX 37 37 ASN A 592 ASN A 595 5 4 HELIX 38 38 THR A 607 ASN A 627 1 21 HELIX 39 39 TRP A 630 GLY A 634 5 5 HELIX 40 40 THR A 643 GLY A 669 1 27 HELIX 41 41 ASN A 680 TRP A 693 1 14 HELIX 42 42 ARG A 698 ASP A 709 1 12 HELIX 43 43 PRO A 713 ASN A 724 1 12 HELIX 44 44 SER A 725 PHE A 732 1 8 SHEET 1 A 2 ARG A 102 GLY A 104 0 SHEET 2 A 2 GLY A 695 TYR A 697 -1 N THR A 696 O TYR A 103 SHEET 1 B 4 ASN A 201 ASP A 207 0 SHEET 2 B 4 ASN A 210 ASP A 219 -1 N ASN A 210 O ASP A 207 SHEET 3 B 4 ASP A 342 VAL A 345 1 O ASP A 342 N ILE A 216 SHEET 4 B 4 LYS A 301 THR A 303 -1 O MET A 302 N VAL A 343 SHEET 1 C 3 LYS A 476 GLY A 480 0 SHEET 2 C 3 GLN A 551 PRO A 555 1 N ILE A 552 O LYS A 476 SHEET 3 C 3 PHE A 544 SER A 546 -1 O PHE A 544 N VAL A 553 SSBOND 1 CYS A 56 CYS A 61 1555 1555 2.04 SSBOND 2 CYS A 79 CYS A 734 1555 1555 2.03 SSBOND 3 CYS A 87 CYS A 694 1555 1555 2.03 SSBOND 4 CYS A 142 CYS A 410 1555 1555 2.04 SSBOND 5 CYS A 233 CYS A 241 1555 1555 2.05 SSBOND 6 CYS A 620 CYS A 746 1555 1555 2.04 LINK ND2 ASN A 144 C1 NAG A 752 1555 1555 1.45 LINK ND2 ASN A 324 C1 NAG A 753 1555 1555 1.45 LINK ND2 ASN A 627 C1 NAG A 754 1555 1555 1.45 LINK NE2 HIS A 583 ZN ZN A 755 1555 1555 2.03 LINK NE2 HIS A 587 ZN ZN A 755 1555 1555 2.01 LINK OE1 GLU A 646 ZN ZN A 755 1555 1555 1.96 LINK O1P RDF A 750 ZN ZN A 755 1555 1555 1.93 CISPEP 1 LYS A 318 PRO A 319 0 -0.09 CISPEP 2 PRO A 561 PRO A 562 0 0.25 CRYST1 107.580 107.580 112.840 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009295 0.005367 0.000000 0.00000 SCALE2 0.000000 0.010733 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008862 0.00000